Landos Biopharma, Inc.
LABP · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$22 | -$39 | -$38 | -$30 |
| Dep. & Amort. | $0 | $1 | $0 | $0 |
| Deferred Tax | $2 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $2 | $4 | $1 |
| Change in WC | $0 | -$10 | $6 | $6 |
| Other Non-Cash | -$2 | $1 | $1 | $0 |
| Operating Cash Flow | -$20 | -$46 | -$27 | -$23 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | -$0 | $0 |
| Inv. Purchases | $0 | -$4 | -$175 | -$22 |
| Inv. Sales/Matur. | $8 | $78 | $117 | $36 |
| Other Inv. Act. | -$0 | $0 | $0 | -$0 |
| Investing Cash Flow | $8 | $74 | -$59 | $14 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $17 | $0 | $93 | $2 |
| Stock Repurch. | -$3 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14 | $0 | $92 | $2 |
| Financing Cash Flow | $14 | $0 | $92 | $2 |
| Forex Effect | $0 | $0 | $0 | -$0 |
| Net Chg. in Cash | $1 | $28 | $6 | -$7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37 | $8 | $2 | $10 |
| End Cash | $38 | $37 | $8 | $2 |
| Free Cash Flow | -$20 | -$46 | -$28 | -$23 |